[Ip-health] Reminder: Webinar tomorrow (Tues, Oct 29): "China’s changing role in the global pharmaceutical system: implications for national and global public health"

Marcela Vieira marcelacfvieira at gmail.com
Mon Oct 28 02:34:49 PDT 2019

Dear all,

Just a gentle reminder that the webinar below "China’s changing role in the
global pharmaceutical system: implications for national and global public
health" is taking place tomorrow (Tuesday, October 29). To register, please
use this link:

We hope you will be able to join us for this discussion! In case you can't
attend it live, the recording will be available a few days after at

All the best,

Marcela Vieira.

*China’s changing role in the global pharmaceutical system: implications
for national and global public health*

Tuesday 29 October | 4 pm - 5 pm CET | 10 am - 11 am CDT
To join the webinar, please register here:

Peter Yu, Professor of Law, Professor of Communication and Director of the
Center for Law and Intellectual Property at Texas A&M University

Yuanqiong Hu, Postdoctoral Research Associate at the School of Law, SOAS,
University of London and Senior Legal and Policy Advisor for the Access
Campaign of Médecins Sans Frontières (MSF)

1) Peter K. Yu. "China’s Innovative Turn and the Changing Pharmaceutical
Landscape" (2019)
Available at: https://www.ssrn.com/abstract=3437632


China plays a central role in the global pharmaceutical landscape as the
leading supplier of active pharmaceutical ingredients (APIs) for the
worldwide production of brand-name and generic medicines alike. The country
has also increased the production of finished pharmaceutical products and
has invested heavily in innovation in the pharmaceutical sector. National
regulation of intellectual property rights has changed over time and new
proposals are currently being discussed following the fast-evolving
dynamics of the Chinese industry. How will that affect the global
pharmaceutical landscape? What are the implications for public health
policies and China’s international relations at the domestic, regional and
global levels?

Prof. Peter Yu will present his recent paper (above) examining China’s
innovative turn and its implications for the global pharmaceutical
landscape. He will present the latest proposed changes to the patent law
and regulation on test data protection for pharmaceutical products. He will
provide an analysis of how they might affect innovation and access to
medicines nationally and globally, and China’s position at international
and regional trade forums. Dr. Yuanqiong Hu will then discuss the main
findings and conclusions of the paper, with a focus on the implications for
global policies on access to medicines.

The webinar is free and open to the public and will be held in English.
Participants will be able to pose questions orally or in writing, and the
speakers will respond to a selection of these during the second half of the
event. Recordings of all webinars will be made available at the Knowledge
Portal on Innovation and Access to Medicines. After registering, you will
receive a confirmation email with additional information on how to join the
webinar using the Zoom platform.

Marcela Vieira
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines

Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira at graduateinstitute.ch

More information about the Ip-health mailing list